相似文献
1
Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.
Cell Mol Life Sci. 2010 Aug;67(15):2605-18. doi: 10.1007/s00018-010-0338-2. Epub 2010 Mar 18.
2
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Theranostics. 2018 Mar 8;8(8):2202-2216. doi: 10.7150/thno.24003. eCollection 2018.
3
The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Curr Pharm Des. 2015;21(10):1279-91. doi: 10.2174/1381612821666141211115611.
4
The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Epub 2010 May 15.
5
Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):135-47. doi: 10.1007/s10911-010-9179-8. Epub 2010 May 9.
6
Cellular dynamics of EMT: lessons from live in vivo imaging of embryonic development.
Cell Commun Signal. 2021 Jul 22;19(1):79. doi: 10.1186/s12964-021-00761-8.
7
Endothelial induced EMT in breast epithelial cells with stem cell properties.
PLoS One. 2011;6(9):e23833. doi: 10.1371/journal.pone.0023833. Epub 2011 Sep 6.
8
ErbB/EGF signaling and EMT in mammary development and breast cancer.
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):191-9. doi: 10.1007/s10911-010-9172-2. Epub 2010 Apr 6.
9
Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.
J Cell Physiol. 2017 Dec;232(12):3261-3272. doi: 10.1002/jcp.25797. Epub 2017 Apr 10.
10
Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.
Oncogene. 2014 Nov 6;33(45):5238-50. doi: 10.1038/onc.2013.467. Epub 2013 Nov 4.
引用本文的文献
1
Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation.
BMC Cancer. 2022 Mar 4;22(1):240. doi: 10.1186/s12885-022-09285-x.
2
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.
Int J Mol Sci. 2022 Jan 29;23(3):1565. doi: 10.3390/ijms23031565.
3
Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.
J Histochem Cytochem. 2021 Dec;69(12):749-773. doi: 10.1369/00221554211025482. Epub 2021 Jun 24.
4
Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
BMC Cancer. 2021 Feb 26;21(1):200. doi: 10.1186/s12885-020-07722-3.
5
The dark-side of the outside: how extracellular heat shock proteins promote cancer.
Cell Mol Life Sci. 2021 May;78(9):4069-4083. doi: 10.1007/s00018-021-03764-3. Epub 2021 Feb 5.
6
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.
Front Immunol. 2020 Oct 21;11:2166. doi: 10.3389/fimmu.2020.02166. eCollection 2020.
7
AGO1 enhances the proliferation and invasion of cholangiocarcinoma via the EMT-associated TGF-β signaling pathway.
Am J Transl Res. 2020 Jun 15;12(6):2890-2902. eCollection 2020.
8
Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells.
Sci Rep. 2019 Feb 28;9(1):2991. doi: 10.1038/s41598-019-39545-z.
9
LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer.
Oncotarget. 2019 Feb 1;10(10):1014-1030. doi: 10.18632/oncotarget.26583.
10
Immunoexpression of N-cadherin, Twist and Vimentin in Bladder Urothelial Carcinomas.
Curr Health Sci J. 2015 Jul-Sep;41(3):219-226. doi: 10.12865/CHSJ.41.03.05. Epub 2015 Jan 29.
本文引用的文献
1
TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.
Nature. 2010 Feb 4;463(7281):676-80. doi: 10.1038/nature08734.
2
Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.
Cell. 2010 Jan 8;140(1):62-73. doi: 10.1016/j.cell.2009.12.007.
3
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion.
EMBO Mol Med. 2009 Sep;1(6-7):338-51. doi: 10.1002/emmm.200900039.
4
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Clin Cancer Res. 2010 Jan 1;16(1):45-55. doi: 10.1158/1078-0432.CCR-09-1630. Epub 2009 Dec 22.
5
Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
Neoplasia. 2009 Dec;11(12):1318-28. doi: 10.1593/neo.91084.
6
Epithelial-mesenchymal transitions in development and disease.
Cell. 2009 Nov 25;139(5):871-90. doi: 10.1016/j.cell.2009.11.007.
7
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Nat Cell Biol. 2009 Dec;11(12):1487-95. doi: 10.1038/ncb1998. Epub 2009 Nov 22.
8
MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.
Sci Signal. 2009 Oct 13;2(92):ra62. doi: 10.1126/scisignal.2000356.
9
Cancer stem cells: mirage or reality?
Nat Med. 2009 Sep;15(9):1010-2. doi: 10.1038/nm0909-1010. Epub 2009 Sep 4.
10
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
J Clin Invest. 2009 Sep;119(9):2678-90. doi: 10.1172/JCI37815. Epub 2009 Aug 24.
Zotero 插件